logo
logo
Sign in

Rising Adoption Of OTC Drugs Are Fueling The Growth Of Hyperhidrosis Treatment Market

avatar
Pooja Khodke
Rising Adoption Of OTC Drugs Are Fueling The Growth Of Hyperhidrosis Treatment Market

Market Overview:


Hyperhidrosis refers to excessive sweating beyond what is physiologically required for thermoregulation. This condition can significantly affect the patients' quality of life by causing embarrassment and discomfort during social or professional interactions. The hyperhidrosis treatment market offers various topical treatment options including over-the-counter drugs such as antiperspirants, anticholinergic drugs, botulinum toxin injections and iontophoresis that help manage excessive sweating.


The global Hyperhidrosis Treatment Market is estimated to be valued at Us$ 641.54 Mn in 2023 and is expected to exhibit a CAGR Of 5.6% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:


The rising adoption of over-the-counter drugs for hyperhidrosis treatment is a major trend witnessed in the market. According to various studies, more than 50% of the hyperhidrosis patients rely on over-the-counter antiperspirants/deodorants for managing their sweating issues. These products provide temporary relief for 1-3 days from underarm sweating and are widely available and affordable. Some popular OTC drugs include Certain Dri, Driclor, SweatBlock Clinical Strength, etc. Their growing uptake can be attributed to factors such as self-treatment preferences, immediate results and avoidance of medical expenses. This increasing reliance on OTC drugs is expected to remain a key trend in the hyperhidrosis treatment market over the forecast period.


Segment Analysis


The global hyperhidrosis treatment market is segmented into two major sub segments namely axillary hyperhidrosis and palmar hyperhidrosis. Among these, the axillary hyperhidrosis sub segment dominates the market with maximum share owing to its high prevalence. Axillary hyperhidrosis is characterized by excessive sweating under the arms which can often interfere with daily activities and affect quality of life.

Key Takeaways

The Global Hyperhidrosis Treatment Market Size is expected to witness high growth, exhibiting CAGR of 5.6% over the forecast period, due to increasing awareness about treatment options and growing consumer inclination towards aesthetic procedures.

Regional analysis


North America dominates the global hyperhidrosis treatment market and is expected to remain the fastest growing region through 2030. This can be attributed to the availability of advanced treatment options and presence of key players in the region. The Asia Pacific region is anticipated to emerge as the most lucrative market in the coming years owing to increasing healthcare expenditure and rising medical tourism in the emerging economies like China and India.

Key players


Key players operating in the hyperhidrosis treatment market are GSK Plc (U.K.), TheraVida (U.S.), Revance (U.S.)., NovaMedica. (Russia), Ulthera, Inc. (U.S.), DEMIRA e.V (Germany), Abbvie, Inc (U.S.), Fresh Tracks Therapeutics, Inc. (U.S.), Dr. August Wolff GmbH (Germany), Dermavant Sciences, Inc. (U.S.), Eirion Therapeutics, Inc (U.K.). These companies are mainly focussing on new product development and strategic collaborations to strengthen their market position.


Get more insights on this topic: 


https://www.insightprobing.com/rising-prevalence-of-hyperhidrosis-to-boost-the-growth-of-the-global-hyperhidrosis-treatment-market/

collect
0
avatar
Pooja Khodke
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more